Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mathieu Roumiguie

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Urologic Oncology|January 18, 2020
Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy featuresMathieu Roumiguie, Marine Lesourd, Joseph Zgheib, et al.
World Journal of Urology|May 11, 2018
Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french studyLouis Lenfant, Gregory Verhoest, Riccardo Campi, et al.
Translational Andrology and Urology|September 18, 2020
Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomyScott Geiger, Neil Kocher, Dan Illinsky, et al.
Cancers|February 27, 2020
The Urinary Transcriptome as a Source of Biomarkers for Prostate CancerCarla Solé, Ibai Goicoechea, Alai Goñi, et al.
World Journal of Urology|October 17, 2012
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative databaseLaurent Nison, Morgan Rouprêt, Grégory Bozzini, et al.
European Urology Oncology|April 22, 2025
Oncological Safety and Diagnostic Yield of Percutaneous Needle-core Biopsies in Upper Tract Urothelial Carcinoma: The UPERCUT StudyDoriane Prost, Atanas Pachev, Eric De Kerviler, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
World Journal of Urology|May 13, 2026
Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancerManon Cournède, Pierre-Etienne Gabriel, Marine Lottin, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
World Journal of Urology|May 26, 2025
Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the "jump" of the lamina propria layer mythGabrielle Tissot, Pierre-Etienne Gabriel, Ulysse Dubuet, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Urologic Oncology|January 18, 2020
Improvement of the intermediate risk prostate cancer sub-classification by integrating MRI and fusion biopsy featuresMathieu Roumiguie, Marine Lesourd, Joseph Zgheib, et al.
World Journal of Urology|May 11, 2018
Perioperative outcomes and complications of intracorporeal vs extracorporeal urinary diversion after robot-assisted radical cystectomy for bladder cancer: a real-life, multi-institutional french studyLouis Lenfant, Gregory Verhoest, Riccardo Campi, et al.
Translational Andrology and Urology|September 18, 2020
Comparison of the Comprehensive Complication Index and Clavien-Dindo systems in predicting perioperative outcomes following radical nephroureterectomyScott Geiger, Neil Kocher, Dan Illinsky, et al.
Cancers|February 27, 2020
The Urinary Transcriptome as a Source of Biomarkers for Prostate CancerCarla Solé, Ibai Goicoechea, Alai Goñi, et al.
World Journal of Urology|October 17, 2012
The oncologic impact of a delay between diagnosis and radical nephroureterectomy due to diagnostic ureteroscopy in upper urinary tract urothelial carcinomas: results from a large collaborative databaseLaurent Nison, Morgan Rouprêt, Grégory Bozzini, et al.
European Urology Oncology|April 22, 2025
Oncological Safety and Diagnostic Yield of Percutaneous Needle-core Biopsies in Upper Tract Urothelial Carcinoma: The UPERCUT StudyDoriane Prost, Atanas Pachev, Eric De Kerviler, et al.
Cancers|December 11, 2022
Oncological Outcomes for Patients Harboring Positive Surgical Margins Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Multicentric Study on Behalf of the YAU Urothelial GroupGautier Marcq, Luca Afferi, Yann Neuzillet, et al.
World Journal of Urology|May 13, 2026
Multi-institutional external validation of the European risk classification for high-grade Ta non-muscle-invasive bladder cancerManon Cournède, Pierre-Etienne Gabriel, Marine Lottin, et al.
World Journal of Urology|January 12, 2026
Second-look transurethral resection in high-grade Ta non-muscle invasive bladder cancerSophie Régnier, Pierre-Etienne Gabriel, Idir Ouzaid, et al.
World Journal of Urology|May 26, 2025
Impact on oncological outcomes of detrusor muscle absence in pTaHG urothelial carcinoma of the bladder? The end of the "jump" of the lamina propria layer mythGabrielle Tissot, Pierre-Etienne Gabriel, Ulysse Dubuet, et al.
Pageof 4